AIGH Capital Management’s Coya Therapeutics COYA Stock Holding History

AIGH Capital Management’s Portfolio COYA Stock Details COYA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.7M	Sell	631,912 -343,492	-35%	-$1.59M	0.23%	39
2026 Q1	$3.84M	Hold	975,404	–	–	0.52%	28
2025 Q4	$5.66M	Sell	975,404 -130,218	-12%	-$792K	1.37%	22
2025 Q3	$6.3M	Hold	1,105,622	–	–	1.78%	21
2025 Q2	$6.36M	Sell	1,105,622 -78,158	-7%	-$453K	2.86%	16
2025 Q1	$7.66M	Sell	1,183,780 -17,372	-1%	-$110K	3.17%	13
2024 Q4	$6.88M	Buy	1,201,152 +551,725	+85%	+$3.76M	2.15%	18
2024 Q3	$4.19M	Hold	649,427	–	–	1.18%	22
2024 Q2	$3.94M	Hold	649,427	–	–	1.23%	21
2024 Q1	$6.44M	Sell	649,427 -382,550	-37%	-$3M	1.93%	12
2023 Q4	$7.38M	Buy	1,031,977 +496,183	+93%	+$2.75M	2.92%	11
2023 Q3	$2.06M	Sell	535,794 -51,078	-9%	-$203K	0.98%	30
2023 Q2	$2.39M	Buy	586,872 +26,872	+5%	+$125K	0.97%	27
2023 Q1	$2.22M	Hold	560,000	–	–	0.82%	30
2022 Q4	$2.65M	Buy	+560,000	New	+$2.61M	0.87%	26

Other funds holding COYA

DCM

DME Capital Management New York $3.91B AUM 36.1% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return

PMG

Private Management Group Irvine, California $3.8B AUM 23.19% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

AIGH Capital Management's COYA Position: Q2 2026 in Review

AIGH Capital Management reduced its Coya Therapeutics (COYA) stake by 35% in Q2 2026, selling an estimated $1.59M and leaving 631,912 shares worth $3.7M. The position accounts for 0.23% of the portfolio, ranked #39.

AIGH Capital Management first reported a position in COYA in Q4 2022 and has held it in 15 quarters since. The position peaked at $7.66M in Q1 2025. 54 funds tracked by Wall St. Rank hold COYA as of Q2 2026.

AIGH Capital Management held 631,912 shares of Coya Therapeutics worth $3.7M as of Q2 2026.
AIGH Capital Management sold 343,492 Coya Therapeutics shares in Q2 2026, an estimated $1.59M.
Coya Therapeutics made up 0.23% of AIGH Capital Management's portfolio in Q2 2026, its #39 holding.
AIGH Capital Management first reported a position in Coya Therapeutics in Q4 2022 and has held it in 15 quarters since.
AIGH Capital Management's Coya Therapeutics position peaked at $7.66M in Q1 2025.
54 funds tracked by Wall St. Rank held Coya Therapeutics as of Q2 2026.

Based on AIGH Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.